DaVita Inc. is a leading healthcare company specializing in kidney dialysis services, operating through a vast network of outpatient centers across the United States and internationally. Founded in 1992 by a group of physicians committed to a patient-centered, coordinated approach to care, DaVita has grown to serve hundreds of thousands of patients with chronic kidney disease. The company’s name, derived from the Italian phrase “da re vita” meaning “to give life,” reflects its core mission to improve clinical outcomes and enhance the quality of life for those it serves.

Headquartered in Denver, Colorado, DaVita manages 2,657 outpatient dialysis centers in the U.S., accounting for 36% of the total dialysis patient population nationally. Additionally, the company operates 585 centers in 14 other countries, extending its life-saving services to a global patient base. DaVita’s comprehensive care model includes not only dialysis treatments but also supportive services aimed at managing the broader health needs of patients with chronic kidney disease.

DaVita is publicly traded on the New York Stock Exchange under the ticker symbol DVA and is a component of the S&P 500. The company continues to innovate in renal care, investing in clinical research and technology to advance the standard of care for kidney patients worldwide. Through its dedicated team of healthcare professionals, DaVita remains a cornerstone in the fight against kidney disease.